Clinical Trials Logo
  1. Home
  2. Anastomotic Leakage
  3. NCT04846283

Drainage Fluid Biomarkers and Anastomotic Leakage in Colorectal Surgery. A Monocentric Prospective Observational Study — ALbiomarkers  

Anastomotic Leakage Clinical Trial

Official title:
Drainage Fluid Biomarkers And Anastomotic Leakage In Colorectal Surgery. A Monocentric Prospective Observational Study

Clinical Trial Summary

Anastomotic leakage (AL) is one of the most feared intra-abdominal septic complications (IASC) after colorectal surgery. It is defined as the leak of intestinal content due to an anastomotic dehiscence. Incidence ranges from 2% to 20%. AL is usually associated to systemic inflammatory response, even if in some cases the presentation may be subclinical. Therefore, AL is suspected in patients with a strong inflammatory response and can be confirmed by imaging with contrast enhanced computed tomography (CT) scan or water-soluble contrast studies. Nevertheless, imaging has varying sensitivity and specificity and is usually performed once the patient has a clinical evidence, thus potentially delaying the correct timing for surgery. Despite several studies about this topic and the plenty of known risk factors as mentioned above, AL is still not easy to predict. Different tools other than imaging have been studied in order to make diagnosis of AL at an early stage, as the measurement of some biomarkers of inflammation in serum and in drainage fluid. Biomarkers as white cell blood count (WBC), C-reactive protein (CRP), cytokines (e.g. TNFa, IL-6, IL-1b), markers of ischemia (e.g. lactate) and procalcitonin (PCT) have been used for an early detection of AL and other intra-abdominal septic complications. The primary aim of our study was to assess the role of drainage fluid CRP and lactate-dehydrogenase (LDH) in the early detection of anastomotic leakage.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04846283
Study type Observational
Source University of Palermo
Contact
Status Completed
Phase
Start date June 1, 2018
Completion date April 1, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01696682 - The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow? N/A
Active, not recruiting NCT02881359 - SEAL Registry - European Registry for the Effectiveness of LifeSeal® Kit
Active, not recruiting NCT03690687 - Delayed Small-Bowel Anastomosis in Patients With Postoperative Peritonitis
Recruiting NCT00942526 - Oral Anti-Infective Agent for Esophageal Anastomotic Leakage Phase 2
Completed NCT02718729 - Anastomotic Leakage Following Laparoscopic Resection for Rectal Cancer N/A
Recruiting NCT05191602 - The Relationship Between Drainage Fluid and Anastomotic Leakage After Colorectal Cancer Surgery
Recruiting NCT00876551 - Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks N/A
Completed NCT00642525 - Detection of Anastomotic Leakage After Esophageal Surgery N/A
Not yet recruiting NCT06049758 - D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy N/A
Completed NCT02686567 - Use of the TDT for Prevention of Anastomotic Leakage After Laparoscopic Anterior Resection for Rectal Cancer N/A
Completed NCT05293054 - Healing of Rectal Anastomosis Sealed With a Concentrate Derived From the Patient's Blood, After Rectal Cancer Surgery
Completed NCT02347735 - Predictive Factors for Anastomotic Leakage After Colorectal Surgery
Completed NCT04319835 - Local Metabolism of the Gastric Tube Reconstruction After Esophagectomy N/A
Completed NCT00686569 - Mediastinal Microdialysis in Patients With Oesophageal or Cardia Cancer Treated by Resection N/A